Bal Pharma Limited (BOM:524824)

India · Delayed Price · Currency is INR

72.00

-2.86 (-3.82%)

At close: Mar 4, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals	3.03B	3.39B	3.04B	2.81B	2.51B
Pharmaceuticals Growth	-10.65%	11.51%	8.18%	12.25%	46.43%
Total	3.03B	3.39B	3.04B	2.81B	2.51B
Total Growth	-10.65%	11.51%	8.18%	12.25%	46.43%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Unallocated	88.10M	128.75M	24.72M	13.36M	35.69M
Unallocated Growth	-31.57%	420.73%	85.02%	-62.55%	-
India	1.10B	1.17B	924.33M	847.73M	874.12M
India Growth	-5.40%	26.30%	9.04%	-3.02%	37.22%
Exports	1.83B	2.09B	2.08B	1.94B	1.58B
Exports Growth	-12.29%	0.37%	7.26%	22.58%	52.28%
Total	3.02B	3.39B	3.03B	2.80B	2.49B
Total Growth	-10.65%	11.71%	8.17%	12.38%	48.69%

Source: S&P Global Market Intelligence.